Search results
Results from the WOW.Com Content Network
Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. [3] [4] As one of the world's largest independent biotechnology companies, Amgen has approximately 24,000 staff in total as of 2022.
In December 2022, the company announced it would be acquired by Amgen for $27.8 billion ($116.50 in cash for each Horizon share, a 20% premium). [17] The company was reportedly the center of a bidding war between Amgen, Johnson & Johnson and Sanofi. [18]
Amgen added Uplizna via a $27.8 billion acquisition of Horizon Therapeutics and recorded sales of $80 million in the first quarter of 2024. The trial met its primary endpoint, showing a ...
(Reuters) -Amgen said on Tuesday that its drug helped improve daily activities including chewing and swallowing in patients suffering from a rare muscle-weakening disease, meeting the main goal of ...
Shares of Amgen, which fell by less than 1% to close at $314.72 on Nasdaq, were unchanged after hours. (Reporting By Deena Beasley and Sneha S K; Editing by Bill Berkrot, Shailesh Kuber and Jamie ...
Amgen's entrant in the weight-loss drug gold rush is called MariTide, and it's currently in phase 2 clinical trials. Thanks to how favorable the preliminary phase 2 data is, management is already ...
This page was last edited on 12 August 2008, at 04:49 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may ...
(Reuters) -Amgen will test its obesity drug candidate in patients at risk of weight-related conditions such as heart, liver and kidney diseases in its late-stage trial, the company's CEO Robert ...